EA201301024A1 - Способ уменьшения подобных гриппу симптомов, ассоциированных с внутримышечным введением интерферона, при использовании режима быстрого титрования повышающейся дозой - Google Patents
Способ уменьшения подобных гриппу симптомов, ассоциированных с внутримышечным введением интерферона, при использовании режима быстрого титрования повышающейся дозойInfo
- Publication number
- EA201301024A1 EA201301024A1 EA201301024A EA201301024A EA201301024A1 EA 201301024 A1 EA201301024 A1 EA 201301024A1 EA 201301024 A EA201301024 A EA 201301024A EA 201301024 A EA201301024 A EA 201301024A EA 201301024 A1 EA201301024 A1 EA 201301024A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- symptoms associated
- therapeutically effective
- effective dose
- interferon
- intraferman
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
Abstract
Изобретение обеспечивает способ лечения рассеянного склероза (MS) и предназначено для снижения подобных гриппу симптомов, ассоциированных с введением интерферона пациенту с MS. Данный способ предусматривает внутримышечное введение интерферона пациенту с MS в соответствии с режимом повышающейся дозировки в недели 1-3 и полной терапевтически эффективной дозы интерферона в неделю 4. В одном воплощении изобретения режим повышающейся дозировки включает введение одной четверти терапевтически эффективной дозы в неделю 1, половинной терапевтически эффективной дозы в неделю 2, трех четвертей терапевтически эффективной дозы в неделю 3. Также обеспечиваются упаковки для титрования, которые позволяют соблюсти режим терапии с изменяющейся дозировкой интерферона в течение периода времени.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161452807P | 2011-03-15 | 2011-03-15 | |
US201161476930P | 2011-04-19 | 2011-04-19 | |
PCT/US2012/029201 WO2012125809A1 (en) | 2011-03-15 | 2012-03-15 | Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201301024A1 true EA201301024A1 (ru) | 2014-03-31 |
EA028448B1 EA028448B1 (ru) | 2017-11-30 |
Family
ID=46045072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201301024A EA028448B1 (ru) | 2011-03-15 | 2012-03-15 | Способ снижения тяжести подобных гриппу симптомов, ассоциированных с лечением пациента с рассеянным склерозом, и набор для титрования для снижения тяжести подобных гриппу симптомов, ассоциированных с лечением пациента с рассеянным склерозом |
Country Status (24)
Country | Link |
---|---|
US (5) | US9198955B2 (ru) |
EP (1) | EP2686002B1 (ru) |
JP (2) | JP6279905B2 (ru) |
KR (1) | KR102050339B1 (ru) |
CN (1) | CN103702680A (ru) |
AU (1) | AU2012229104B2 (ru) |
BR (1) | BR112013023609A8 (ru) |
CA (1) | CA2846786C (ru) |
CY (1) | CY1120176T1 (ru) |
DK (1) | DK2686002T3 (ru) |
EA (1) | EA028448B1 (ru) |
ES (1) | ES2666850T3 (ru) |
HR (1) | HRP20180621T1 (ru) |
HU (1) | HUE036931T2 (ru) |
IL (1) | IL228425A (ru) |
LT (1) | LT2686002T (ru) |
MX (1) | MX359947B (ru) |
PL (1) | PL2686002T3 (ru) |
PT (1) | PT2686002T (ru) |
RS (1) | RS57175B1 (ru) |
SG (1) | SG193446A1 (ru) |
SI (1) | SI2686002T1 (ru) |
WO (1) | WO2012125809A1 (ru) |
ZA (1) | ZA201306933B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2686002T1 (en) * | 2011-03-15 | 2018-06-29 | Biogen Ma Inc. | A method for reducing influenza-like symptoms associated with intramuscular delivery of interferon by the rapid titration-enhancing regimen |
US10106775B2 (en) | 2014-01-09 | 2018-10-23 | Kyushu University, National University Corporation | Method of producing microglial cells |
US11266344B2 (en) | 2016-09-21 | 2022-03-08 | Samsung Electronics Co., Ltd. | Method for measuring skin condition and electronic device therefor |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4456748A (en) | 1981-02-23 | 1984-06-26 | Genentech, Inc. | Hybrid human leukocyte interferons |
EP0070906B1 (en) | 1981-02-04 | 1986-10-15 | Juridical Foundation Japanese Foundation For Cancer Research | Human interferon-beta gene |
US4695543A (en) | 1982-03-23 | 1987-09-22 | Bristol-Myers Company | Alpha Interferon GX-1 |
CA1302320C (en) | 1984-06-11 | 1992-06-02 | Hideo Niwa | Expression of human cromosomal interferon-_ in animal cells |
US5231176A (en) | 1984-08-27 | 1993-07-27 | Genentech, Inc. | Distinct family DNA encoding of human leukocyte interferons |
FI90990C (fi) | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi |
US4885166A (en) | 1985-06-11 | 1989-12-05 | Ciba-Geigy Corporation | Hybrid interferons |
US5641656A (en) | 1993-10-22 | 1997-06-24 | University Of Connecticut | Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them |
JP4878664B2 (ja) * | 1996-12-24 | 2012-02-15 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 安定な液体インターフェロン処方物 |
JP2001104482A (ja) * | 1999-10-07 | 2001-04-17 | Terumo Corp | 2室型プレフィルドシリンジ |
ES2712469T3 (es) * | 2003-01-30 | 2019-05-13 | Becton Dickinson Co | Soporte con escudo de seguridad para un dispositivo de administración de fármaco |
EA010979B1 (ru) * | 2004-06-01 | 2008-12-30 | Арес Трейдинг С.А. | Стабилизированные жидкие препаративные формы интерферона |
EP1923085A1 (en) * | 2006-11-17 | 2008-05-21 | Sanofi-Aventis Deutschland GmbH | Dosing and drive mechanism for drug delivery device |
WO2008076819A2 (en) | 2006-12-18 | 2008-06-26 | Altus Pharmaceuticals Inc. | Human growth hormone formulations |
JP5549048B2 (ja) * | 2007-08-16 | 2014-07-16 | 味の素株式会社 | 薬剤バイアルとプレフィルドシリンジの接続構造 |
JP2012530721A (ja) * | 2009-06-18 | 2012-12-06 | ワイス・エルエルシー | 小モジュール免疫薬のための凍結乾燥製剤 |
SI2686002T1 (en) * | 2011-03-15 | 2018-06-29 | Biogen Ma Inc. | A method for reducing influenza-like symptoms associated with intramuscular delivery of interferon by the rapid titration-enhancing regimen |
-
2012
- 2012-03-15 SI SI201231281T patent/SI2686002T1/en unknown
- 2012-03-15 RS RS20180455A patent/RS57175B1/sr unknown
- 2012-03-15 US US13/421,197 patent/US9198955B2/en active Active
- 2012-03-15 LT LTEP12719487.6T patent/LT2686002T/lt unknown
- 2012-03-15 PL PL12719487T patent/PL2686002T3/pl unknown
- 2012-03-15 DK DK12719487.6T patent/DK2686002T3/en active
- 2012-03-15 WO PCT/US2012/029201 patent/WO2012125809A1/en active Application Filing
- 2012-03-15 HU HUE12719487A patent/HUE036931T2/hu unknown
- 2012-03-15 EA EA201301024A patent/EA028448B1/ru unknown
- 2012-03-15 BR BR112013023609A patent/BR112013023609A8/pt not_active Application Discontinuation
- 2012-03-15 ES ES12719487.6T patent/ES2666850T3/es active Active
- 2012-03-15 AU AU2012229104A patent/AU2012229104B2/en active Active
- 2012-03-15 CA CA2846786A patent/CA2846786C/en active Active
- 2012-03-15 EP EP12719487.6A patent/EP2686002B1/en active Active
- 2012-03-15 JP JP2013558168A patent/JP6279905B2/ja active Active
- 2012-03-15 KR KR1020137027053A patent/KR102050339B1/ko active IP Right Grant
- 2012-03-15 PT PT127194876T patent/PT2686002T/pt unknown
- 2012-03-15 SG SG2013069018A patent/SG193446A1/en unknown
- 2012-03-15 MX MX2013010507A patent/MX359947B/es active IP Right Grant
- 2012-03-15 CN CN201280019863.2A patent/CN103702680A/zh active Pending
-
2013
- 2013-09-12 ZA ZA2013/06933A patent/ZA201306933B/en unknown
- 2013-09-12 IL IL228425A patent/IL228425A/en active IP Right Grant
-
2015
- 2015-11-09 US US14/936,228 patent/US20160101157A1/en not_active Abandoned
-
2017
- 2017-09-05 US US15/695,587 patent/US10500254B2/en active Active
- 2017-09-05 JP JP2017170640A patent/JP6522069B2/ja active Active
-
2018
- 2018-04-18 HR HRP20180621TT patent/HRP20180621T1/hr unknown
- 2018-04-23 CY CY20181100424T patent/CY1120176T1/el unknown
-
2019
- 2019-10-22 US US16/660,038 patent/US20200046804A1/en not_active Abandoned
-
2022
- 2022-05-27 US US17/827,282 patent/US20220280610A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020004023A (es) | Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia. | |
EA201491773A1 (ru) | Лечение рассеянного склероза комбинацией лаквинимода и диметилфумарата | |
EA201490254A1 (ru) | Комбинированное лечение гепатита с | |
UA113403C2 (xx) | Спосіб підвищення ефективності folr1 терапії раку | |
NZ703940A (en) | Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor | |
EA201490378A1 (ru) | ЛЕЧЕНИЕ РАССЕЯННОГО СКЛЕРОЗА С ИСПОЛЬЗОВАНИЕМ КОМБИНАЦИИ ЛАХИНИМОДА И ИНТЕРФЕРОНА-β | |
IN2015DN00376A (ru) | ||
EA201590166A8 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
BR112012033738A2 (pt) | método para o tratamento de transtorno bipolar | |
BR112015010396A2 (pt) | terapia de combinação | |
EA202091640A1 (ru) | Способы лечения опосредованного il-6 воспаления без иммунодепрессии | |
EA201791043A1 (ru) | Комбинированная терапия бокового амиотрофического склероза | |
EA201391387A1 (ru) | Нейропротекторные пептиды | |
MX2022015629A (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
CY1120176T1 (el) | Μεθοδος για τη μειωση των συμπτωματων που μοιαζουν με αυτα της γριπης που συνδεονται με ενδομυϊκη χορηγηση ιντερφερονης με τη χρηση ενος σχηματος κλιμακουμενης δοσολογιας ταχειας τιτλοδοτησης | |
EA201490495A1 (ru) | Новые легкоразрушающиеся ингибиторы rock | |
EA201370230A1 (ru) | Новые ингибиторы rock | |
EA201591507A1 (ru) | Лечение рассеянного склероза лахинимодом | |
MX2021007330A (es) | Composiciones y métodos terapéuticos para tratar cáncer usando ácido 6, 8-bis-benciltio-octanoico y un inhibidor de autofagia. | |
EA201400424A1 (ru) | Фармацевтическая композиция и набор для лечения бактериальных инфекций | |
MX2022001200A (es) | Metodo para el tratamiento de accidente cerebrovascular usando un derivado triciclico. | |
CY1120669T1 (el) | Συνδυαστικη θεραπεια για αγωγη σκληρυνσης κατα πλακας | |
AR098924A1 (es) | Tratamiento de la esclerosis múltiple con una combinación de laquinimod y teriflunomida | |
MX2012012712A (es) | Composicion farmaceutica para uso en el tratamiento o prevencion de una o varias enfermedaes inflamatorias y/o enfermedades autoinmunitarias. | |
RU2012156088A (ru) | Способ лечения вульгарной пузырчатки |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Registration of transfer of a eurasian patent by assignment |